Kyverna Therapeutics Inc (KYTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -89,988 | -55,496 | -26,693 | -60,366 | -39,699 |
| Depreciation Amortization | 1,570 | 1,012 | 482 | 1,707 | 1,245 |
| Accounts payable and accrued liabilities | 6,034 | 967 | 3,068 | 4,083 | 1,104 |
| Other Working Capital | 7,823 | 2,570 | -1,838 | 3,424 | 2,415 |
| Other Operating Activity | -2,628 | 1,247 | -544 | -1,258 | 1,088 |
| Operating Cash Flow | $-77,189 | $-49,700 | $-25,525 | $-52,410 | $-33,847 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -188,451 | -189,229 | -122,336 | -8,164 | -40,179 |
| PPE Investments | -1,673 | -1,571 | -543 | -621 | -287 |
| Investing Cash Flow | $-190,124 | $-190,800 | $-122,879 | $-8,785 | $-40,466 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 59,900 | 59,900 |
| Debt Repayment | -709 | -467 | -231 | -781 | -562 |
| Common Stock Issued | 341,398 | 341,308 | 341,235 | 645 | 370 |
| Other Financing Activity | -3,361 | -3,361 | -2,955 | -1,646 | -156 |
| Financing Cash Flow | $337,328 | $337,480 | $338,049 | $58,118 | $59,552 |
| Beginning Cash Position | 35,212 | 35,212 | 35,212 | 38,289 | 38,289 |
| End Cash Position | 105,227 | 132,192 | 224,857 | 35,212 | 23,528 |
| Net Cash Flow | $70,015 | $96,980 | $189,645 | $-3,077 | $-14,761 |
| Free Cash Flow | |||||
| Operating Cash Flow | -77,189 | -49,700 | -25,525 | -52,410 | -33,847 |
| Capital Expenditure | -1,673 | -1,571 | -543 | -621 | -287 |
| Free Cash Flow | -78,862 | -51,271 | -26,068 | -53,031 | -34,134 |